Adjunctive Cancer Care Using
Repurposed Drugs & Metabolic Interventions
Evidence-based integrative cancer treatment. Partnered with Rebuild Medicine
for groundbreaking 5-year outcomes research. Telehealth in all 50 states.
Why Experience with Repurposed Drug Protocols Matters in Cancer Care
Integrative cancer care using repurposed drugs and metabolic interventions is not well understood by conventional cancer treatment. Most integrative providers have limited clinical experience with these protocols — and most oncologists dismiss them entirely. The difference between working with a provider who has treated dozens of cancer patients with repurposed drugs versus one who has treated hundreds is that we're thinking about cancer in ways that conventional treatment is not.
Conventional treatment focuses on killing cancer cells — surgery, chemotherapy, radiation, immunotherapy. Our approach addresses the underlying metabolic dysfunction that allows cancer to develop and thrive in the first place. This isn't about replacing conventional treatment. It's about improving patient quality of life, extending life expectancy beyond what traditional treatment achieves alone, and giving patients real tools to support their bodies through treatment and beyond.
At Leading Edge Clinic, adjunctive cancer care isn't a side specialty — it's a core focus of our practice. Our clinical team has:
- 500+ cancer patients treated in just 2 years with repurposed drugs and metabolic interventions
- Clinical application of Dr. Paul Marik's cancer care protocols — translating published research into personalized patient care
- Partnership with Rebuild Medicine on a groundbreaking 5-year observational outcomes study
- Experience across all cancer types and stages — from active treatment to remission maintenance to prevention
We didn't start treating cancer patients because it was a popular integrative medicine trend. We started because Dr. Kory's voracious desire to learn and find better treatments drove us to explore what the research was showing about repurposed drugs and metabolic interventions. What we found was compelling evidence that these approaches, when used alongside conventional treatment, improve patient outcomes. And now, with hundreds of patients treated, we know they work because we've seen it.
If you're also being treated for Long Covid or Post-Vaccine Syndrome, our expertise spans multiple complex conditions — all grounded in the same metabolic and integrative approach.
Our Adjunctive Cancer Care Specialists
Our providers combine deep understanding of cancer biology and treatment with expertise in repurposed drugs and metabolic interventions.
Dr. Kris Lee
Dr. Kris Lee is a physician specializing in adjunctive cancer care and repurposed drug protocols for cancer treatment. Her practice is dedicated exclusively to adjunctive cancer care, combining evidence-based metabolic interventions with a deep understanding of cancer biology and treatment.
Clinical Focus:
- Adjunctive cancer care
- Repurposed drug protocols
- Metabolic interventions
- Cancer remission maintenance
- Cancer prevention
- All cancer types and stages
Why Patients Choose Dr. Lee:
Dr. Lee's clinical approach is rooted in published research on repurposed drugs and metabolic therapy for cancer. Her protocols are informed by Dr. Paul Marik's pioneering work in this field, combined with her own clinical experience treating hundreds of cancer patients.
Patients describe Dr. Lee as thorough, evidence-focused, and willing to work collaboratively alongside their oncology team to provide the best possible integrative care.
Learn More About Dr. LeeBriana Bowden
Briana Bowden is a Nurse Practitioner specializing in adjunctive cancer care, metabolic health, and complex chronic illness. Her integrative approach addresses not only the cancer itself but the full spectrum of metabolic and immune dysfunction that often accompanies it.
Clinical Focus:
- Adjunctive cancer care
- Repurposed drug protocols
- Metabolic interventions
- Gut health & microbiome
- Hormone optimization
- Thyroid & adrenal support
Why Patients Choose Briana:
Briana is known for her comprehensive, whole-person approach to cancer care. She understands that cancer is often a metabolic disease, and her protocols address the underlying metabolic dysfunction that allows cancer to develop and progress.
Her work with patients includes not only repurposed drug protocols but also targeted nutritional interventions, gut health restoration, and hormone balance — all of which play critical roles in cancer treatment and prevention.
Briana's expertise extends to Long Covid and Post-Vaccine Syndrome, as well as mycotoxin illness and other complex chronic conditions.
Learn More About BrianaDr. Pierre Kory
Dr. Pierre Kory is a board-certified internal medicine and critical care physician who has integrated his extensive critical care background with evidence-based integrative medicine principles. His approach to adjunctive cancer care is informed by decades of clinical experience managing complex, life-threatening illness.
Clinical Focus:
- Adjunctive cancer care
- Repurposed drug protocols
- Critical care perspective
- Pulmonary conditions
- Long Covid & Post-Vaccine Syndrome
- DMSO treatment protocols
Why Patients Choose Dr. Kory:
Dr. Kory's background in critical care medicine gives him a unique perspective on cancer treatment. He understands disease progression, systemic inflammatory response, and organ support at a level that most integrative providers don't possess.
His work with repurposed drug protocols for cancer builds on his broader experience treating complex chronic illness and his willingness to challenge medical dogma when evidence supports better approaches.
Dr. Kory also specializes in Long Covid and Post-Vaccine Syndrome treatment, pulmonary conditions, and DMSO protocols.
Learn More About Dr. KoryDebbie Moyer, AGPCNP
Specializes in adjunctive cancer care, Post-Vaccine Syndrome, Long Covid, and DMSO treatment. Brings adult-gerontology expertise to cancer care protocols.
Learn More →Scott Marsland, FNP-C
Specializes in adjunctive cancer care, Long Covid, Post-Vaccine Syndrome, and complex chronic illness. Known for meticulous clinical approach and personalized protocols.
Learn More →Leading Edge Clinic's Partnership with
Rebuild Medicine: 5-Year Cancer Outcomes Study
Leading Edge Clinic is partnering with Rebuild Medicine on a groundbreaking 5-year observational study tracking real-world outcomes for cancer patients treated with repurposed drug protocols and metabolic interventions. This is the first long-term, rigorous data collection effort of its kind in integrative oncology.
What the Study Is
The Rebuild Medicine observational study is a 5-year research initiative tracking patient outcomes for cancer patients treated with repurposed drugs and metabolic interventions. Every Leading Edge Clinic cancer patient who consents is enrolled, and their clinical outcomes — including tumor markers, imaging results, symptom burden, and quality of life — are tracked longitudinally.
Why It's Significant
No one else is doing this. While anecdotal case reports exist, there is no rigorous, long-term tracking of repurposed drug protocols in cancer care. This study will provide the kind of real-world evidence that conventional oncology demands — and that integrative medicine has been missing.
How It Benefits Patients
Patients enrolled in the study receive the same individualized care they would otherwise — but with the added benefit of contributing to the evidence base that will help future cancer patients. There is no cost to participate, no additional appointments, and no experimental protocols. You're simply allowing your outcomes to be tracked.
What We're Learning
The study is ongoing, and results will be published at the 5-year mark. Early observations suggest that repurposed drug protocols are well-tolerated, feasible to implement alongside conventional treatment, and associated with meaningful symptom improvement and quality of life gains — but formal conclusions await study completion.
Study Highlights
- 5-year longitudinal tracking
- 500+ cancer patients enrolled
- All cancer types and stages included
- Real-world evidence collection
- Rigorous, transparent methodology
- Partnership with Rebuild Medicine
- Patient-centered research
- No cost to participate
Want to learn more about the observational study and how to participate?
Learn More About the StudyReal-World Results & Clinical Insights
Beyond the research, here's what repurposed drug protocols are achieving in actual patient care — from stage 4 pancreatic cancer to metastatic lung cancer.
Stage 4 Metastatic Pancreatic Cancer:
A Clinical Case Study
Debbie Moyer, AGPCNP, presents a detailed case study of a patient with stage 4 metastatic pancreatic cancer treated with repurposed drug protocols alongside conventional therapy.
This case demonstrates the feasibility, tolerability, and potential benefits of integrating metabolic interventions with standard oncology care — even in one of the most aggressive cancer types.
Watch the full presentation to understand how repurposed drugs were sequenced, monitored, and adjusted throughout the patient's treatment journey.
Ivermectin for Cancer: Scientific Mechanisms & Clinical Outcomes
A comprehensive review of the scientific evidence supporting ivermectin's use in cancer treatment — covering mechanisms of action, published clinical data, and real-world applications across multiple cancer types.
Read the Full ArticleRepurposed Drugs in Oncology: A Case Series in Metastatic Lung Cancer
Dr. Kory presents five stage 4 lung cancer cases treated with repurposed drug protocols, examining current state of the evidence and real-world patient outcomes. A transparent look at what's working — and what we're still learning.
Read the Case Series